Janowsky A - Search Results

1

Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand.

Neve KA, Henningsen RA, Kinzie JM, De Paulis T, Schmidt DE, Kessler RM, Janowsky A. Neve KA, et al. Among authors: janowsky a. J Pharmacol Exp Ther. 1990 Mar;252(3):1108-16. J Pharmacol Exp Ther. 1990. PMID: 2138666

2

Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine.

Janowsky A, Neve KA, Kinzie JM, Taylor B, de Paulis T, Belknap JK. Janowsky A, et al. J Pharmacol Exp Ther. 1992 Jun;261(3):1282-90. J Pharmacol Exp Ther. 1992. PMID: 1534844

3

Characterization and distribution of [125I]epidepride binding to dopamine D2 receptors in basal ganglia and cortex of human brain.

Joyce JN, Janowsky A, Neve KA. Joyce JN, et al. Among authors: janowsky a. J Pharmacol Exp Ther. 1991 Jun;257(3):1253-63. J Pharmacol Exp Ther. 1991. PMID: 1828505

4

Characterization of a recombinant human dopamine transporter in multiple cell lines.

Eshleman AJ, Neve RL, Janowsky A, Neve KA. Eshleman AJ, et al. Among authors: janowsky a. J Pharmacol Exp Ther. 1995 Jul;274(1):276-83. J Pharmacol Exp Ther. 1995. PMID: 7616409

5

Release of dopamine via the human transporter.

Eshleman AJ, Henningsen RA, Neve KA, Janowsky A. Eshleman AJ, et al. Among authors: janowsky a. Mol Pharmacol. 1994 Feb;45(2):312-6. Mol Pharmacol. 1994. PMID: 7906856

6

Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.

Eshleman AJ, Carmolli M, Cumbay M, Martens CR, Neve KA, Janowsky A. Eshleman AJ, et al. Among authors: janowsky a. J Pharmacol Exp Ther. 1999 May;289(2):877-85. J Pharmacol Exp Ther. 1999. PMID: 10215666

7

Increased abundance of alternatively spliced forms of D2 dopamine receptor mRNA after denervation.

Neve KA, Neve RL, Fidel S, Janowsky A, Higgins GA. Neve KA, et al. Among authors: janowsky a. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2802-6. doi: 10.1073/pnas.88.7.2802. Proc Natl Acad Sci U S A. 1991. PMID: 1826366 Free PMC article.

8

(S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-[125I]iodo- 2-methoxybenzamide hydrochloride, a new selective radioligand for dopamine D-2 receptors.

de Paulis T, Janowsky A, Kessler RM, Clanton JA, Smith HE. de Paulis T, et al. Among authors: janowsky a. J Med Chem. 1988 Oct;31(10):2027-33. doi: 10.1021/jm00118a031. J Med Chem. 1988. PMID: 3172140

9

[125I]iodopride: a specific high affinity radioligand for labelling striatal dopamine D-2 receptors.

Janowsky A, De Paulis T, Clanton JA, Smith HE, Ebert MH, Kessler RM. Janowsky A, et al. Eur J Pharmacol. 1988 May 20;150(1-2):203-5. doi: 10.1016/0014-2999(88)90772-8. Eur J Pharmacol. 1988. PMID: 3402540 No abstract available.

10

[3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux.

Johnson RA, Eshleman AJ, Meyers T, Neve KA, Janowsky A. Johnson RA, et al. Among authors: janowsky a. Synapse. 1998 Sep;30(1):97-106. doi: 10.1002/(SICI)1098-2396(199809)30:1<97::AID-SYN12>3.0.CO;2-M. Synapse. 1998. PMID: 9704886

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters